BioAdvance News

Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome’s COVID-19 Antibody Based Treatment

By WebmasterFebruary 3, 2021November 1st, 2024No Comments

Abzena Selected by Immunome to Develop and Manufacture Antibody Cocktail for Immunome’s COVID-19 Antibody Based Treatment

Previous PostAnnovis Bio Receives European Patent for Method of Treating Acute Nerve and Brain Insults
Next PostAnnovis Bio's Lead Candidate ANVS401 Improves Cognitive and Functional Outcomes in Stroke Mice Study